|
![]() |
ciprofloxacin hydrochlorideThis page contains recent news articles, when available, and an overview of ciprofloxacin hydrochloride but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: ciprofloxacin hydrochloride (when available) Ciprofloxacin, a broad-spectrum antiinfective agent of the fluoroquinolone class, is used to treat gram-negative infections, sexually transmitted diseases, mycobacterial infections, corneal ulcers, and bacterial conjunctivitis. For the treatment of Bacterial infection of Respiratory tract, UTI, Uncomplicated Cystitis in females, GI, Chronic Bacterial Prostatitis, CNS, Immuno compromised patients, Skin, Bone and Joint Infections, Uncomplicated cervical and urethral gonorrhea Mechanism Of Action: Ciprofloxacin has in vitro activity against a wide range of gram-negative and gram-positive organisms. Ciprofloxacin inhibits bacterial DNA gyrase, an enzyme responsible for counteracting excessive supercoiling of DNA during replication or transcription. The mechanism of action of quinolones, including ciprofloxacin, is different from that of other antimicrobial agents such as beta-lactams, macrolides, tetracyclines, or aminoglycosides; therefore, organisms resistant to these drugs may be susceptible to ciprofloxacin. There is no known cross-resistance between ciprofloxacin and other classes of antimicrobials. News Articles on Ciprofloxacin Depomed to Present at the 7th Annual Needham & Co. Biotechnology ... - 02 Jun 2008 ProQuin(R) XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary Centre Daily Times, Q&A: About Anthrax - May 29, 2008 A. The preferred antibiotic, ciprofloxacin hydrochloride -- brand name Cipro -- is prescribed for 60 days. Doxycycline, also called tetracycline, Virginia Gazette, Depomed Elects Karen A. Dawes to Board of Directors - Apr 8, 2008 ProQuin(R) XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary FOXBusiness Depomed Reports Preliminary 2007 Year End Financial Results - Mar 6, 2008 ProQuin(R) XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary StreetInsider.com (subscription), Depomed Reports Preliminary 2007 Year End Financial Results - Mar 6, 2008 ...of the company’s license and supply agreements with Esprit Pharma for ProQuin ® XR (ciprofloxacin hydrochloride) in the third quarter of 2007. Business Wire (press release), United States: FTC Takes 4-in-1 Shot At Reverse Payment ... - Feb 28, 2008 The proper legal standard for reverse payment settlements is currently before that circuit in In re Ciprofloxacin Hydrochloride Antitrust Litigation, No. Mondaq News Alerts (subscription), Depomed to Present at the BIO CEO & Investor Conference - Feb 5, 2008 ProQuin(R) XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary FOXBusiness Dutton Associates Announces - Jan 15, 2008 Laiyang Jiangbo?s core products include clarithromycin sustained-release tablets, itopride hydrochloride granules, ciprofloxacin hydrochloride tablets, Ad-Hoc-News (Pressemitteilung), Depomed and King Pharmaceuticals Terminate Promotion Agreement for ... - Oct 29, 2007 Proquin® XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary WELT ONLINE, Marksans Pharma gets European approval - Sep 26, 2007 Ciprofloxacin Hydrochloride is mainly used to treat bacterial infections. Shares of the firm closed at Rs 103.10, up 4.99 per cent at the BSE. Economic Times, Depomed Announces Retirement of Chief Financial Officer John F ... - Oct 11, 2007 Proquin(R) XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary Trading Markets (press release), Marksans Pharma up on European nod for drug - Sep 25, 2007 CHENNAI: Marksans Pharma shares gained on the BSE after the company said that it has received certificate of suitability for its ciprofloxacin hydrochloride Hindu Business Line, Depomed, Watson Expand ProQuin XR Promotion Deal To Obstetrics ... - Sep 25, 2007 ProQuin XR is a once-daily, extended-release formulation of ciprofloxacin hydrochloride for the treatment of uncomplicated urinary tract infections. RTT News, SubSea Resources FY07 Loss Widens - Quick Facts [SUB.L] - Sep 25, 2007 The companies specified that the ProQuin XR is a once-daily, extended-release formulation of ciprofloxacin hydrochloride for the treatment of uncomplicated RTT News, Depomed to Present at Thomas Weisel Partners Annual Healthcare ... - Aug 29, 2007 Proquin ® XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary Business Wire (press release), Depomed Announces Positive Results of Phase 2a Proof-of-Concept ... - Sep 5, 2007 Proquin(R) XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary Genetic Engineering News (press release), [an error occurred while processing this directive] [an error occurred while processing this directive] [an error occurred while processing this directive] [an error occurred while processing this directive] [an error occurred while processing this directive] [an error occurred while processing this directive] [an error occurred while processing this directive] [an error occurred while processing this directive] [an error occurred while processing this directive] [an error occurred while processing this directive] [an error occurred while processing this directive] [an error occurred while processing this directive] [an error occurred while processing this directive] Brand Names/Synonyms: ciprofloxacin hydrochloride is also known by the following brand names and/or synonymsBacquinor; Baycip; Bernoflox; CIPROFLOXACIN HCL; Ciflox; Cifloxin; Ciloxan; Ciprinol; Cipro; Cipro I.V.; Cipro Xl; Cipro Xr; Ciprobay; Ciprocinol; Ciprodar; Ciprofloxacin; Ciprofloxacin Base; Ciprofloxacin Dihydrochloride; Ciprofloxacin Hydrochloride; Ciprofloxacin Monohydrochloride; Ciprofloxacina; Cipromycin; Ciproquinol; Ciproxan; Ciproxin; Flociprin; Floxin; Floxin Otic; Floxin in Dextrose 5%; Ocuflox; Ofloxacin; Proquin Xr; Septicide; Velomonit Drug Category: ciprofloxacin hydrochloride is categorized under the following by the FDA: Anti-Infectives; Quinolones; ATC:J01MA02; ATC:S01AX13; ATC:S03AA07 Dosage Forms: LIQUID; OINTMENT; SOLUTION; SUSPENSION; TABLET; TABLET (COMBINED RELEASE); TABLET (EXTENDED-RELEASE) Absorption: 70-80% Interactions: -->Interactions for Ciprofloxacin: Caffeine Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life. Cyclosporine Some quinolones, including ciprofloxacin, have been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly. Glyburide The concomitant administration of ciprofloxacin with the sulfonylurea glyburide has, on rare occasions, resulted in severe hypoglycemia. Histamine H2-receptor antagonists Histamine H2-receptor antagonists appear to have no significant effect on the bioavailability of ciprofloxacin. Methotrexate Renal tubular transport of methotrexate may be inhibited by concomitant administration of ciprofloxacin, potentially leading to increased plasma levels of methotrexate. This might increase the risk of methotrexate toxic reactions. Therefore, patients under methotrexate therapy should be carefully monitored when concomitant ciprofloxacin therapy is indicated. Multivalent Cation-Containing Products Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired. Proquin XR should be administered at least 4 hours before or 2 hours after these products. This time window is different than for other oral formulations of ciprofloxacin, which are usually administered 2 hours before or 6 hours after antacids. Non-steroidal anti-inflammatory drugs (but not aspirin) These drugs in combination with very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies. Omeprazole The rate and extent of absorption of ciprofloxacin was bioequivalent when Proquin XR was given alone or when Proquin XR was given 2 hours after omeprazole at the dose that maximally suppresses gastric acid secretion. Omeprazole should be taken as directed and Proquin XR should be taken with a main meal of the day, preferably the evening meal.. Phenytoin Altered serum levels of phenytoin (increased and decreased) have been reported in patients receiving concomitant ciprofloxacin. Probenecid Probenecid interferes with renal tubular secretion of ciprofloxacin and produces an increase in the level of ciprofloxacin in serum. Theophylline As with some other quinolones, concurrent administration of ciprofloxacin with theophylline may lead to elevated serum concentrations of theophylline and prolongation of its elimination half-life. This may result in increased risk of theophylline-related adverse reactions. If concomitant use cannot be avoided, serum levels of theophylline should be monitored and dosage adjustments made as appropriate. Warfarin Quinolones have been reported to enhance the effects of the oral anticoagulant warfarin or its derivatives. When these products are administered concomitantly, prothrombin time or other suitable coagulation tests should be monitored. Chemical IUPAC Name: 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1H-quinoline-3-carboxylicacid : |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com
COPYRIGHT 2007 MONGABAY.COM |